Research
Current Projects
Optimizing mobile behavioral economic interventions for rural risky drinkers
The BETTER Living study was designed to recognize and respond to at-risk alcohol use in rural America, where empirically supported treatments are less available, less accessible, and less affordable. This initial feasibility and acceptability study uses a theory-driven mobile behavioral economic intervention aiming to provide tailored treatment regimens, reduce treatment burden, improve outcomes, and increase access for rural Americans. The long-term goal of this research is to bring accessible, efficacious, and theory-driven treatment to people who at-risk alcohol use in rural regions, reducing disparity in treatment needs.
A virtual incentive program to help people quit smoking
Throughout the state of Michigan, tobacco use is the greatest cause of preventable disease, disability, and death. To help people to quit smoking, incentive treatments offer rewards for using services and for quitting smoking. Even with the proven success of incentives to help people quit, this treatment is hard to get for most people who smoke cigarettes. Incentives2Quit uses a smartphone delivered incentive treatment to increase participation in services and successful quit attempts. In this program, participants will be provided monetary incentives for calling the MI Quitlink and quitting smoking.
A Just-in-time adaptive intervention to reduce cannabis use
MiWaves is a mobile health study seeking to refine a just-in-time adaptive intervention (JITAI) to reduce cannabis use among emerging adults. Real-time data will be used to dynamically adjust a mobile phone app to provide intervention content (including empirically based strategies such as motivational interviewing, mindfulness, etc.) that keeps participants engaged. The MiWaves study will also test the feasibility and acceptability of the mobile health app intervention. Reducing cannabis use among emerging adults could have a major public health impact by preventing health consequences (e.g., injury), development of substance use disorders, and associated risk behaviors (e.g., drugged driving).
A prospective observational cohort study of polysubstance use profiles and trajectories
MiBEST is designed to explore the intersections between individual factors, community factors, and social factors of substance use. Using novel assessments to capture detailed polysubstance use and behavioral economic choice preferences, the study will follow up with participants over the course of a year. MiBEST will direct additional attention to treatment barriers, healthcare utilization, and community factors such as treatment availability and county-level data. The goal of this project is to inform practice and policy by providing valuable insight into polysubstance use, which may have significant public health implications.
Evaluating digital contingency management to address co-use of alcohol and opioids.
Opioid overdose killed more than 80,000 Americans in 2022 and 1 in 6 opioid overdoses involve alcohol. Opioid agonist therapies (methadone, buprenorphine) help reduce overdose risk and are a first-line treatment for opioid use disorder. Alcohol use is highly prevalent among those who use opioid agonist therapies and alcohol increases the risk of mortality. This pilot study, co-lead with Dr. Anne Fernandez, will test the feasibility and acceptability of digital contingency management among Medicaid beneficiaries in Michigan on opioid agonist therapies with co-occurring diagnoses of Opioid Use Disorder and Alcohol Use Disorder. The goals of this work are to understand how digital contingency management supports retention on opioid agonist therapies, as well as the impact on opioid and alcohol use.
Co-lead investigator: Anne Fernandez, PhD
